“[18F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab” (2020) Radiology and Oncology, 54(3), pp. 285–294. Available at: https://www.radioloncol.com/index.php/ro/article/view/3452 (Accessed: 25 September 2026).